All Stories

  1. Sunitinib: the antiangiogenic effects and beyond
  2. Primary Systemic Amyloidosis Presenting With Asymmetric Multiple Mononeuropathies
  3. An unusual neurological complication of light chain amyloidosis
  4. Activity of bortezomib administered once every 3 weeks for treatment of relapsed multiple myeloma